A few weeks ago, my cousin asked if I would join her family for her oldest son’s wedding ceremony this November in Dubai. “We’ve started…
Myeloma
Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for 49 people with newly diagnosed…
When my mum, Esther, was diagnosed with myeloma in January 2021, our world split in two. There was the life we thought we were…
I recently went to the supermarket to pick up some groceries. While I was shopping for avocados, an acquaintance approached me. “How is your mother?”…
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years for those diagnosed in 2005…
It started like any ordinary ache — something my mum, Esther, was all too familiar with. She often woke up with a crick in her…
The first time I saw a patient all by himself in the infusion room, I didn’t notice him. No, that’s not what happened. On that…
The U.S. Food and Drug Administration (FDA) has approved two new biosimilar drugs — versions of brand-name therapies that have no clinically meaningful differences compared…
At my last school reunion, someone asked me, “What do you do?” “I am a writer and a columnist,” I said. At the coffee…
This September, during Blood Cancer Awareness Month, major organizations are launching new campaigns to increase awareness and support for the three main types of…
Recent Posts
- Vyriad targets 2026 clinical trial for new experimental cell therapy VV169
- Olverembatinib and chemo show deep response in trial for Ph-positive ALL
- Pancreatic cancer treatment atebimetinib set for Phase 3 trial
- 1st trial participant receives Alpha DaRT radiation therapy for glioblastoma
- How my reflection has changed since becoming a caregiver
